Madrigal Pharmaceuticals, Inc.
(Borse Berlin : SNTA)

( )
SNTA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
2.26%164.370.4%$316.92m
VRXValeant Pharmaceuticals International, Inc.
-0.84%17.1914.1%$105.25m
SAGESAGE Therapeutics, Inc.
-12.77%148.019.7%$81.71m
PRGOPerrigo Co. Plc
-1.41%81.566.6%$75.56m
ICPTIntercept Pharmaceuticals, Inc.
-0.72%68.7318.8%$69.62m
JAZZJazz Pharmaceuticals Plc
-0.49%157.952.2%$65.93m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.24%132.437.6%$56.92m
PCRXPacira Pharmaceuticals, Inc.
1.55%36.0010.7%$54.07m
UTHRUnited Therapeutics Corporation
0.95%114.0614.5%$44.23m
MNKMallinckrodt Plc
-1.92%13.7720.3%$39.40m
ICLRICON Plc
-1.21%117.644.1%$35.28m
CTLTCatalent Inc
0.02%41.902.6%$28.73m
SUPNSupernus Pharmaceuticals, Inc.
-0.72%48.506.3%$28.26m
PTLAPortola Pharmaceuticals, Inc.
0.82%33.257.7%$27.62m
MDCOMedicines Company
-2.09%29.4521.9%$25.84m

Company Profile

Madrigal Pharmaceuticals, Inc. clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel compounds for the treatment of cardiovascular, metabolic and liver diseases. The company offers MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Madrigal Pharmaceuticals was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.